Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01142505Phase 3Completed
Phase 3, randomised, double-blind trial in wheeze comparing Montelukast with Placebo (2 arms). Primary endpoint: Need for unscheduled medical attention at 12 months. Started Nov 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01142505.